C Vilariño-Güell

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Characterization of DCTN1 genetic variability in neurodegeneration
    C Vilariño-Güell
    Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Neurology 72:2024-8. 2009
  2. ncbi LINGO1 rs9652490 is associated with essential tremor and Parkinson disease
    Carles Vilariño-Güell
    Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
    Parkinsonism Relat Disord 16:109-11. 2010
  3. ncbi Association of the MAPT locus with Parkinson's disease
    C Wider
    Department of Neuroscience, Mayo Clinic, Molecular Genetics Laboratory and Core, Morris K Udall Parkinsons Disease Research Center of Excellence, Jacksonville, FL 32224, USA
    Eur J Neurol 17:483-6. 2010
  4. ncbi Death-associated protein kinase 1 variation and Parkinson's disease
    J C Dachsel
    Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    Eur J Neurol 18:1090-3. 2011
  5. ncbi SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study
    C Wider
    Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    Eur J Neurol 18:876-81. 2011
  6. ncbi Susceptibility genes for restless legs syndrome are not associated with Parkinson disease
    C Vilariño-Güell
    Department of Neuroscience, Division of Neurogenetics, Mayo Clinic, Jacksonville, FL 32224, USA
    Neurology 71:222-3. 2008
  7. ncbi Calbindin-1 association and Parkinson's disease
    A I Soto-Ortolaza
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA
    Eur J Neurol 17:208-11. 2010
  8. ncbi A family with Parkinsonism, essential tremor, restless legs syndrome, and depression
    A Puschmann
    Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Neurology 76:1623-30. 2011
  9. ncbi A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease
    Kenya Nishioka
    Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    J Neurol Neurosurg Psychiatry 81:391-5. 2010

Collaborators

Detail Information

Publications9

  1. ncbi Characterization of DCTN1 genetic variability in neurodegeneration
    C Vilariño-Güell
    Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Neurology 72:2024-8. 2009
    ....
  2. ncbi LINGO1 rs9652490 is associated with essential tremor and Parkinson disease
    Carles Vilariño-Güell
    Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
    Parkinsonism Relat Disord 16:109-11. 2010
    ..Our study demonstrates a significant association between LINGO1 rs9652490 and essential tremor (P = 0.014) and Parkinson disease (P = 0.0003), thus providing the first evidence of a genetic link between both diseases...
  3. ncbi Association of the MAPT locus with Parkinson's disease
    C Wider
    Department of Neuroscience, Mayo Clinic, Molecular Genetics Laboratory and Core, Morris K Udall Parkinsons Disease Research Center of Excellence, Jacksonville, FL 32224, USA
    Eur J Neurol 17:483-6. 2010
    ..Whilst an association between the tau gene (MAPT)-containing H1 haplotype and supranuclear gaze palsy (PSP) has long been recognized, the effect of H1 on risk for Parkinson's disease (PD) has remained more contentious...
  4. ncbi Death-associated protein kinase 1 variation and Parkinson's disease
    J C Dachsel
    Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    Eur J Neurol 18:1090-3. 2011
    ..The Lrrk2 protein is a member of the ROCO family, which also includes Lrrk1 and Dapk1. Functional genetic variants of the DAPK1 gene (rs4877365 and rs4878104) have been previously associated with Alzheimer's disease...
  5. ncbi SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study
    C Wider
    Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    Eur J Neurol 18:876-81. 2011
    ..In the current study, we attempt to validate previously published findings, evaluating gene-gene interactions between SNCA, MAPT, and GSK3B in association with PD...
  6. ncbi Susceptibility genes for restless legs syndrome are not associated with Parkinson disease
    C Vilariño-Güell
    Department of Neuroscience, Division of Neurogenetics, Mayo Clinic, Jacksonville, FL 32224, USA
    Neurology 71:222-3. 2008
  7. ncbi Calbindin-1 association and Parkinson's disease
    A I Soto-Ortolaza
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA
    Eur J Neurol 17:208-11. 2010
    ..Recently, an association was reported between the calcium buffer, calbindin (rs1805874) and risk of PD in a Japanese patient-control series...
  8. ncbi A family with Parkinsonism, essential tremor, restless legs syndrome, and depression
    A Puschmann
    Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Neurology 76:1623-30. 2011
    ..Previous epidemiologic and genetic studies have suggested a link between Parkinson disease (PD), essential tremor (ET), and restless legs syndrome (RLS)...
  9. ncbi A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease
    Kenya Nishioka
    Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    J Neurol Neurosurg Psychiatry 81:391-5. 2010
    ..As future therapies are targeted to specific protein abnormalities, identifying the genetic causes and associated clinical and pathological features will determine diagnosis, preventative medicine and drug intervention strategies...